Srensen KK, Mller FT, Yazdanfard PDW, et al
Key Takeaway: Success on a GLP-1 medication comes from a combination of the right clinical support and mindful lifestyle choices that respect your bodys changing needs
This medication operates by slowing down stomach emptying and signaling fullness to the brain, naturally decreasing food intake
This strict protocol reduces absorption variability and may lower nausea incidence compared to weekly injections for some patients
It is one of the few research peptides with a direct path to FDA-approved clinical use afamelanotide received FDA approval in 2019 for the treatment of erythropoietic protoporphyria (EPP), a rare genetic photosensitivity disorder
This condition can lead to pain, nausea, bloating and vomiting of undigested food